Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2Phase 1 2

Status

Unknown 2Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 4Thoracic 1Gynecologic 1

Conditions

Brain Neoplasms 3Gynecologic Cancer 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Interventional × AGuIX × Clear all
NCT04789486 2026-05-14

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Dana-Farber Cancer Institute

Phase 1/2 Recruiting
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04881032 2025-02-13

NANO-GBM

Centre Jean Perrin

Phase 1/2 Active not recruiting
66 enrolled
CNS

Glioblastoma

NCT03818386 2024-06-14

NANORAD2

University Hospital, Grenoble

Phase 2 Unknown
100 enrolled
CNS

Brain Neoplasms

NCT03308604 2021-07-07

NANOCOL

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Unknown
18 enrolled
Gynecologic

Gynecologic Cancer

NCT04094077 2021-06-08

NANOSTEREO

Centre Leon Berard

Phase 2 Terminated
1 enrolled
CNS

Brain Neoplasms

NCT02820454 2019-06-07

NANO-RAD

University Hospital, Grenoble

Phase 1 Completed
15 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡